Common questions about Lamisil (Oral) (FAQ)
Q: What is the active ingredient in Lamisil oral tablets?
The active ingredient in Lamisil Oral tablets is terbinafine, which is chemically known as terbinafine hydrochloride.
Q: Is Lamisil Oral an antibiotic?
No, Lamisil Oral, which contains terbinafine, is classified as an antifungal medication. It works by stopping the growth of fungi, unlike antibiotics, which primarily target bacteria.
Q: Does Lamisil Oral treat all types of fungal infections?
Official documentation specifies that Lamisil Oral is indicated for infections caused by certain fungi, such as onychomycosis of the fingernail and toenail. It is also sometimes used for other specific fungal infections of the skin or scalp. It is not listed as treating all possible types of fungal infections.
Q: What is the main difference between Lamisil oral tablets and the cream for ringworm or athlete's foot?
The main difference is the method of delivery. Lamisil Oral tablets are designed for systemic delivery, meaning the medicine travels through the bloodstream to reach the infection site from within the body. In contrast, the cream is a topical treatment applied only to the surface of the skin.
Q: Is there a maximum time length for taking Lamisil Oral that is generally discussed in regulatory documents?
The duration of Lamisil Oral treatment is fixed according to the approved use. For approved nail infections, treatment is typically fixed at 6 weeks for fingernail infections and 12 weeks for toenail infections. These fixed durations represent the typical length of the prescribed course.
Q: What is the difference in how Lamisil Oral is used for fungal skin infections versus nail infections?
Official labeling approves Lamisil Oral for nail infections (onychomycosis) with courses of 6 or 12 weeks. The medicine is also sometimes used to treat certain fungal skin infections, such as ringworm or jock itch, which typically require a shorter duration of treatment.
Q: What are the general expectations about how long it takes to see results with Lamisil Oral?
According to official patient information, the full clearance of the infection may not be evident until several months after the treatment course is completed. This is related to the time needed for the healthy nail to grow out.
Q: What happens if I miss a dose of Lamisil Oral?
Regulatory guidance suggests taking the missed dose as soon as it is remembered. However, if the time until the next scheduled dose is less than four hours, the missed dose is generally skipped, and the regular schedule is resumed.
Q: Are there specific age restrictions for who can use Lamisil Oral?
Lamisil Oral tablets are primarily used in adults, but official labeling describes a weight-based dosing method for use in children. Regulatory labeling indicates that the safety and effectiveness of the tablets for treating nail infections in children has not been established.
Q: Is there any official information on Lamisil Oral use in children?
Official documents confirm that the medicine is sometimes used for certain fungal infections in children. When used, dosing is determined by the child’s body weight using specific thresholds listed in the regulatory guidance.
Q: Why do official documents state that Lamisil Oral is not for pregnant women?
Official documents state that the medicine should generally not be started during pregnancy because the treatment for fungal nail infections can usually be delayed until after the pregnancy. Current data on the use of oral terbinafine during human pregnancy is limited.
Q: Are there any specific liver risks associated with taking Lamisil Oral that I should know about?
Official regulatory documents describe a risk of liver injury, known as hepatotoxicity, associated with oral terbinafine. In rare cases, this has progressed to serious outcomes such as liver failure. Due to this potential risk, monitoring of liver function tests is described in official guidance as being performed before starting and periodically throughout the treatment.
Q: What are the signs of liver issues mentioned in the safety information for Lamisil Oral?
Official safety information lists signs of potential liver issues that have been reported. These signs include persistent nausea, fatigue, loss of appetite, vomiting, pain in the upper right abdomen, dark urine, or jaundice (yellowing of the skin/eyes).
Q: Do you have to avoid alcohol completely while taking Lamisil Oral, according to official warnings?
Official guidance discourages the use of Lamisil Oral in patients with pre-existing chronic or active liver disease. Consuming alcohol while taking the medicine is often noted as a factor that may increase the potential risk of liver problems.
Q: Can I take Lamisil Oral if I have a history of lupus?
Regulatory documents indicate that the onset or worsening (exacerbation) of cutaneous and systemic lupus erythematosus has been reported with the use of this medicine. Due to this potential effect, official documents state that the use of this medicine requires careful consideration in patients with pre-existing lupus.
Q: What are the rare but serious side effects of Lamisil Oral described in official prescribing information?
Rare but serious effects described in official prescribing information include liver failure, severe skin reactions (like Stevens-Johnson syndrome), severe neutropenia (low white blood cell count), and the onset or worsening of lupus erythematosus.
Q: Does official information suggest Lamisil Oral should be stopped immediately if I feel sick?
Yes, official guidance states that the medicine is typically discontinued immediately if symptoms suggesting a severe side effect, such as clinical signs of liver injury, are experienced.
Q: What kind of monitoring is typically mentioned in official sources for patients taking Lamisil Oral?
Official documentation indicates that liver function tests are typically performed before starting and periodically during the treatment course. Monitoring of complete blood counts is also sometimes considered, especially if the treatment continues for more than six weeks in certain patient groups.
Q: Why does Lamisil Oral sometimes need blood tests during the course of treatment?
Blood tests are used for monitoring potential adverse effects, specifically to check liver function before and periodically during treatment. They are also sometimes used to monitor neutrophil counts (a type of white blood cell) in patients receiving prolonged treatment.
Q: Can Lamisil Oral be taken if someone is also taking antidepressants or anxiety medications?
Official information indicates that oral terbinafine may affect how the body processes certain medications, specifically those broken down by the CYP2D6 enzyme. This group includes certain tricyclic antidepressants, SSRIs, and some beta-blockers. Official documents describe that other medicines may require dose adjustments when taken with Lamisil Oral.
Q: Does taking Lamisil Oral affect blood thinners like warfarin?
Yes, taking oral terbinafine with the blood thinner warfarin may increase the risk of bleeding. Regulatory guidance states that close monitoring of blood clotting levels is typically performed when these two medicines are used together.
Q: Is it described in official sources that Lamisil Oral interacts with birth control pills?
Official sources indicate that oral terbinafine is generally not expected to reduce the effectiveness of oral contraceptives (birth control pills). However, reports of breakthrough bleeding have been noted in some cases.
Q: Is it common for Lamisil Oral to cause stomach upset or nausea?
Yes, official documents list gastrointestinal symptoms among the common adverse events reported in clinical trials. These commonly reported symptoms include nausea, abdominal pain, diarrhea, and indigestion (dyspepsia).
Q: Can Lamisil Oral cause changes in my sense of taste or smell?
Yes, official sources describe reports of taste disturbance, including loss of taste, and smell disturbance, including loss of smell, as potential side effects. These sensory changes may be severe, and in some instances, have been reported as prolonged or permanent.
Q: Are there any long-term effects described in official documents after stopping Lamisil Oral?
Regulatory documents report that disturbances in the sense of taste or smell may occasionally be prolonged, lasting for more than one year, or potentially permanent, even after the medication has been discontinued.
Q: Can Lamisil Oral cause temporary vision changes?
Yes, official sources report that visual disturbances, including blurred vision and reduced visual acuity (sharpness), have been reported as potential side effects.
Q: Does Lamisil Oral make you more sensitive to the sun?
Photosensitivity reactions, meaning increased sensitivity to sunlight, have been reported as a side effect. Official documentation advises that patients typically avoid sunlamps and tanning beds, and use sunscreen and protective clothing when outdoors.
Q: Is it true that Lamisil Oral can sometimes cause a rash or hives?
Yes, official information confirms that rash and urticaria (hives) are among the dermatological symptoms reported by patients. Rash is listed as a common adverse event.
Q: What should I watch out for if I think Lamisil Oral is causing a skin reaction?
Serious skin and hypersensitivity reactions have been reported, including rash and hives. If a progressive skin rash or any signs suggestive of a severe skin reaction occur, regulatory information states that the medicine is typically discontinued.
Q: Can Lamisil Oral affect hair loss or hair growth?
Alopecia, which is hair loss or thinning, is listed in regulatory documents as a very rare side effect reported in the post-marketing surveillance setting.
Q: Are changes in blood count something mentioned as a possible side effect of Lamisil Oral?
Yes, regulatory documents describe hematologic effects, including reported cases of severe neutropenia, which is a significant decrease in a type of white blood cell count. Transient decreases in absolute lymphocyte counts have also been noted.
